Cargando…

Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames

BACKGROUND: Skin neurofibromas represent one of the main clinical manifestations of neurofibromatosis 1, and their number varies greatly between individuals. Quantifying their number is an important step in the methodology of many clinical studies, but counting neurofibromas one by one in individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Karin SG, Rozza-de-Menezes, Rafaela E, Andrade, Raquel M, Theos, Amy, Luiz, Ronir R, Korf, Bruce, Geller, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267434/
https://www.ncbi.nlm.nih.gov/pubmed/25475340
http://dx.doi.org/10.1186/s13023-014-0202-9
_version_ 1782349145140363264
author Cunha, Karin SG
Rozza-de-Menezes, Rafaela E
Andrade, Raquel M
Theos, Amy
Luiz, Ronir R
Korf, Bruce
Geller, Mauro
author_facet Cunha, Karin SG
Rozza-de-Menezes, Rafaela E
Andrade, Raquel M
Theos, Amy
Luiz, Ronir R
Korf, Bruce
Geller, Mauro
author_sort Cunha, Karin SG
collection PubMed
description BACKGROUND: Skin neurofibromas represent one of the main clinical manifestations of neurofibromatosis 1, and their number varies greatly between individuals. Quantifying their number is an important step in the methodology of many clinical studies, but counting neurofibromas one by one in individuals with thousands of tumors is arduous, time-consuming, and subject to intra and interexaminer variability. We aimed to evaluate the efficacy of a new methodology for skin neurofibromas quantification using paper frames. METHODS: The sample comprised 92 individuals with NF1. Paper frames, with a central square measuring 100 cm(2), were placed on the back, abdomen and thigh. Images were taken, transferred to a computer and two independent examiners counted the neurofibromas. The average number of neurofibromas/100 cm(2) of skin was obtained from the mean of the three values. The differences in the quantity of neurofibromas counted by two examiners were evaluated with Intraclass correlation coefficient (ICC), paired t-test, Bland-Altman and survival-agreement plots. To evaluate the predictive value of the method in obtaining the total number of neurofibromas, 49 participants also had their tumors counted one by one. Reproducibility was assessed with Pearson’s correlation coefficients and simple linear regression model. RESULTS: There was excellent agreement between examiners (ICC range 0.992-0.997) and the total number of skin neurofibromas could be predicted by the adhesive frames technique using a specific formula (P < 0.0001). CONCLUSIONS: In this article we describe a reliable, easy and rapid technique using paper frames to quantify skin neurofibromas that accurately predicts the total number of these tumors in patients with NF1. This method may be a useful tool in clinical practice and clinical research to help achieve an accurate quantitative phenotype of NF1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-014-0202-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4267434
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42674342014-12-17 Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames Cunha, Karin SG Rozza-de-Menezes, Rafaela E Andrade, Raquel M Theos, Amy Luiz, Ronir R Korf, Bruce Geller, Mauro Orphanet J Rare Dis Research BACKGROUND: Skin neurofibromas represent one of the main clinical manifestations of neurofibromatosis 1, and their number varies greatly between individuals. Quantifying their number is an important step in the methodology of many clinical studies, but counting neurofibromas one by one in individuals with thousands of tumors is arduous, time-consuming, and subject to intra and interexaminer variability. We aimed to evaluate the efficacy of a new methodology for skin neurofibromas quantification using paper frames. METHODS: The sample comprised 92 individuals with NF1. Paper frames, with a central square measuring 100 cm(2), were placed on the back, abdomen and thigh. Images were taken, transferred to a computer and two independent examiners counted the neurofibromas. The average number of neurofibromas/100 cm(2) of skin was obtained from the mean of the three values. The differences in the quantity of neurofibromas counted by two examiners were evaluated with Intraclass correlation coefficient (ICC), paired t-test, Bland-Altman and survival-agreement plots. To evaluate the predictive value of the method in obtaining the total number of neurofibromas, 49 participants also had their tumors counted one by one. Reproducibility was assessed with Pearson’s correlation coefficients and simple linear regression model. RESULTS: There was excellent agreement between examiners (ICC range 0.992-0.997) and the total number of skin neurofibromas could be predicted by the adhesive frames technique using a specific formula (P < 0.0001). CONCLUSIONS: In this article we describe a reliable, easy and rapid technique using paper frames to quantify skin neurofibromas that accurately predicts the total number of these tumors in patients with NF1. This method may be a useful tool in clinical practice and clinical research to help achieve an accurate quantitative phenotype of NF1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-014-0202-9) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-05 /pmc/articles/PMC4267434/ /pubmed/25475340 http://dx.doi.org/10.1186/s13023-014-0202-9 Text en © Cunha et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cunha, Karin SG
Rozza-de-Menezes, Rafaela E
Andrade, Raquel M
Theos, Amy
Luiz, Ronir R
Korf, Bruce
Geller, Mauro
Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title_full Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title_fullStr Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title_full_unstemmed Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title_short Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
title_sort validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267434/
https://www.ncbi.nlm.nih.gov/pubmed/25475340
http://dx.doi.org/10.1186/s13023-014-0202-9
work_keys_str_mv AT cunhakarinsg validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT rozzademenezesrafaelae validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT andraderaquelm validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT theosamy validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT luizronirr validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT korfbruce validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes
AT gellermauro validityandinterexaminerreliabilityofanewmethodtoquantifyskinneurofibromasofneurofibromatosis1usingpaperframes